Dr. Reddy's CPS Showcases Integrated APIs and Finished Drug Dosage Offerings
Dr. Reddy's Custom Pharma Services launches a new Center of Excellence that further advances its unique integrated drug substance and & drug product manufacturing capabilities.
Dr. Reddy's Custom Pharma Services (CPS) draws on Dr. Reddy's expertise in pharmaceutical development and manufacturing. CPS provides pharmaceutical innovators customized services and solutions for starting materials, intermediates, active ingredients, and finished dosage forms. Dedicated to accelerating innovation and time-to-market, CPS has expanded its existing custom service facilities with a new formulation development laboratory in Miyapur, Hyderabad, India. Bringing together both API and formulation teams in one location will accelerate development as well as project timelines. With this expansion, the laboratories form a Center of Excellence for fully integratedAPI and formulation development services, including:
- Pre-formulation studies
- Prototype formulation development
- Process development
These development capabilities will seamlessly integrate CPS’ offerings of cGMP supplies for clinical trials, registration batches, and commercial manufacture. As with all Dr. Reddy’s facilities, the new Center of Excellence was built and operates in accordance with the latest cGMP regulatory guidelines.
CPS’ partners are uniquely positioned for success, as they have access to the best talent and technologies such as peptides, chirals, highly potent APIs , steroids, and activated mPEGs, as well as a vast product portfolio (intermediates, APIs, drug product). Plus, partners can leverage CPS’ extensive global delivery network to quickly respond to market demands. Capitalizing on cost leadership and a global presence, Dr. Reddy’s partnership model, together with extensive regulatory support, enables pharma companies to efficiently reach more target markets. Thispartnership model underscores Dr. Reddy’s commitment to partner success – because good health can’t wait.